Market Research Blog

[250 Pages Report] As per Future Market Insights’ latest industry analysis, the global pressotherapy systems market size reached around US$ 174.0 Mn in 2021 and is set to grow at 4.1% CAGR over the forecast period (2022-2032).

Attribute	Key Statistics
Pressotherapy Systems Market Size (2021)	US$ 174.0 Mn
Value-based CAGR 2022-2032	4.1%
Market Share of Top 5 Countries	46.9%

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3668

Due to sedentary lifestyles and an aging population, there has been a rapid surge in diseases like diabetes and peripheral edema. This has resulted in the rising usage of lipo-laser and acoustic wave therapy, which is a major factor accelerating growth in the global pressotherapy systems market.

Physical activity, especially competitive activity, brings about in the human body several detrimental alterations. When muscle cells are damaged, chemicals such as creatine kinase (CK), lactate dehydrogenase, and others are produced, which leads to inflammation.

In such circumstances, there is observed, a decline in performance, accelerated muscle aging, a reduction in range of motion, and the onset of pain in the overloaded area. Eccentric workouts, which involve vigorous exercise that may result in delayed onset muscle soreness, are particularly aggravating to this issue.

Treatments in the fields of physical therapy, such as cold and heat therapy, massage, compression therapy, and electrotherapy, manual therapy, and pharmaceuticals are some of the most often utilized strategies for biological recovery.

Of the aforementioned techniques, compression therapy has received a lot of attention recently, with External Pneumatic Compression (EPC) and Intermittent Pneumatic Compression receiving the most attention (IPC). Pressotherapy is also recognized as IPC.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-3668

Additionally, the establishment of the Lymphedema Framework in the region of Europe honors the efforts of nations like France, Germany, the Netherlands, and Spain that made it possible for local reimbursement of compression garments. The UK Department of Health’s choice to include compression garments for lymphedema on the UK Drug Tariff as of 1 March 2006 was influenced by the formulation of the Lymphedema Framework’s own guidelines.

Thus, owing to the growing incidence of circulation problems and fluid retention, as well as the initiatives taken by the regional governments in promoting product utilization, the market for pressotherapy systems is expected to witness a steady growth rate during the forecast period.

Key Takeaways from Market Study

• Based on product, system/pump is the leading segment, holding approximately 9% market value share in 2021.
• By end user, specialty clinics segment accounted for the largest share of 64% of the global pressotherapy systems market in 2021 while the medical spas segment is expected to grow at the fastest CAGR of 5% during the assessment period.
• North America lead the global pressotherapy systems market with around 2% share in 2021, owing to the high prevalence of chronic diseases in the region.
• Europe is expected to remain the second most lucrative market for pressotherapy systems, accounting for around 1% market share value in 2021.
• Pressotherapy systems market in East Asia is likely to grow at the fastest CAGR of 5.6% between 2022 and 2032.

“The pressotherapy systems market will expand steadily over the assessment period due to increased consumer awareness of product availability and growing demand for compression therapy in injury cases,” says an analyst of Future Market Insights.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-3668

Market Competition

Key players in the pressotherapy systems market are involved in new product designs with morphologic technology to better suit the target consumer/patient base. The market for pressotherapy systems is competitive with many players within the compression and wound therapy space.

• In January 2019, Baldan Group launched Iridium Eye Pressotherapy.
• In May 2019, preliminary data, presented at the Symposium on Advanced Wound Care, spring, May 2019, San Antonio TX USA, showed Lympha Press PCD-51 effective at healing chronic venous stasis ulcers (Mego Afek AC LTD.)

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the pressotherapy systems market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.

The research study is based on the product – (system/pump, sleeves, and other accessories), and end user (medical spas, and specialty clinics), and across seven key regions of the world.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[345 Pages Report] As per Future Market Insights’ latest industry analysis, the global cholesterol API market was valued at around US$ 258.4 Mn in 2021 and is projected to exhibit a CAGR of 4.7% over the forecast period (2022-2032). The global market is estimated to be valued at US$ 426.9 Mn in 2032.

Liposomes are a very important part of any drug delivery system with many beneficial properties such as easy preparation, bilayer structure assembling the cellular membrane, and high biocompatibility. Extensive efforts have been dedicated to the use of cholesterol in liposome-based formulations.

Cholesterol, being an integral part of any biological membrane, plays a significant role in liposomal formulations. Liposomes with higher cholesterol content are highly stable.

According to a study by Ascension Sciences published in December 2020, parameters like stability, size, and encapsulation efficiency are used during liposome formulation. Stability of a liposome formulation is greatly influenced by the amount of cholesterol present. A higher percentage of cholesterol favors the development of larger liposomes with less encapsulation effectiveness and higher drug retention.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15406

Despite various applications of liposomes, including diagnosis, food products, gene delivery, drug & vaccine delivery, and biosensor manufacturing, their use is severely constrained by their physicochemical instability. Cholesterol plays a crucial role in the stability of a liposomal membrane.

Moreover, cholesterol affects fluidity, drug retention, phospholipid packing, transition temperature (Tm), permeability, elasticity, membrane strength, and plasma stability. Researchers are set to use cholesterol as a promising substance for the stability of liposomes.

Owing to the aforementioned factors, the global cholesterol API market is set to gain traction over the forecast period.

Key Takeaways: Cholesterol API Market

• By source, the animal-derived segment held approximately 7% of the cholesterol API market share in 2021 owing to their easy availability and low cost.
• By manufacturing process, the GMP segment is set to generate a market share of around 9% by 2032.
• By end user, the monoclonal antibodies segment is projected to grow at a CAGR of 0% during the forecast period.
• East Asia cholesterol API market is expected to showcase the highest CAGR of 6% among all other regions from 2022 to 2032.
• The U.S. cholesterol API market is anticipated to exhibit growth at a lucrative CAGR of 6% during the forecast period.

“Rising demand for RNA vaccines and monoclonal antibodies is projected to drive growth in the next decade. Besides, increasing use of liposomal formulations in drug delivery systems is set to propel sales of cholesterol APIs across the globe,” says an analyst of Future Market Insights.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15406

Competitive Landscape: Cholesterol API Market

The cholesterol API market is highly fragmented and it includes a variety of regional, start-up, and established companies. In order to increase their market share, key players are signing a large number of agreements and engaging in mergers & acquisitions, as well as collaborations.

For instance,

• In May 2021, CordenPharma and the Otto-von-Guericke-University of Magdeburg, Germany developed a scalable synthesis of pharma-grade cholesterol which is used as part of the lipid cocktail for the assembly of effective mRNA-based vaccines.
• In May 2020, Evonik announced €25m first stage of a new long-term program to support the high demand for contract manufacturing of APIs and advanced intermediates across Europe.

Get More Insights on Cholesterol API Market

Future Market Insights offers a unique perspective and actionable insights on the cholesterol API market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the source (animal-derived, plant-derived, and synthetic), manufacturing process (GMP and non-GMP), and end user (RNA vaccines, monoclonal antibodies, and others) across seven key regions of the world.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15406

Cholesterol API Market Outlook by Category

By Source:

• Animal Derived
• Plant Derived
• Synthetic

By Manufacturing Process:

• GMP
• Non – GMP

By End User:

• RNA Vaccines
• Monoclonal Antibodies
• Others

Latest Insights on the Global Staphylococcus Aureus Testing Market

An ongoing study of the research analysts at Future Market Insights (FMI), offers a thorough quantitative and qualitative assessment of the Staphylococcus Aureus Testing market along with easy to grasp tables, graphs, and figures. The Coronavirus (COVID-19) pandemic has caused disruptions in supply chain of the Staphylococcus Aureus Testing market. However, gradual relaxations in complete full and partial lockdowns are anticipated to ease business processes in near term. Companies in the Staphylococcus Aureus Testing market can gain insights about recent developments of COVID-19 and its impact on the Staphylococcus Aureus Testing market. Get a hands-on over our upcoming report on the Staphylococcus Aureus Testing market to gain an edge over other market players. The market study bifurcates the global Staphylococcus Aureus Testing market in different segments to enhance the reading experience of our clients in its upcoming report.

Download Methodology of this Report @ https://www.futuremarketinsights.com/askus/rep-gb-5284

The various segments covered in the report are as follows.

By Application

• Pharmaceutical
•  Clinical
•  food testing
•  other

 By End-Use

• Hospitals
•  Diagnostic Clinics
• Food Testing laboratories
•  others

To know more about this market, request a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-5284

Competitive outlook

The competitive outlook tracks the business proceeding of top-tier market players involved in the Staphylococcus Aureus Testing market. The company profile provides a clear understanding of the growth strategies adopted by various market players.

Key companies covered in the study:

• Abbott Laboratories Inc.
• Siemens Healthcare GmbH
• Bio Rad Laboratories Inc.

Key takeaways from the presented market analysis:

•          In-depth understanding of the innovations in the Staphylococcus Aureus Testing market space

•          Region-wise assessment of the different factors expected to influence market growth in each region

•          Influence of technological advances on the Staphylococcus Aureus Testing market

•          A thorough assessment of growth opportunities for market players in different regions

•          Analysis of the supply-demand ratio in different end-use industries

The market analysis provides answers to some important questions related to the Staphylococcus Aureus Testing market:

1.         What is the most common observable trend within the Staphylococcus Aureus Testing market?

2.        Which region is set to register the maximum growth in terms of value and market share?

3.         Which market players in the Staphylococcus Aureus Testing market are at the forefront in terms of product/technology innovation?

4.        Is the current Staphylococcus Aureus Testing market landscape favorable for new market entrants?

5.         Which end-use industry is expected to generate the maximum demand for Staphylococcus Aureus Testing during the forecast period?

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/5284

Reasons to Opt for Future Market Insights  

•          One of the most established market research firms in India

•          Serving domestic and international clients 24/7

•          Prompt and efficient customer service

•          Data collected from reliable primary and secondary sources

•          Highly trained and experienced team of research analysts

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[300 Pages Report] The global catheter-directed thrombolysis market is expected to be worth US$ 432.0 million in 2022, rising at a 5.9% CAGR to be worth US$ 814.0 million by 2032.

Catheter-directed Thrombolysis Infection Market: Drivers and Restraints

The primary factor driving the growth of catheter-directed thrombolysis market is increasing the prevalence of stroke, pulmonary embolism and deep vein thrombosis around the globe. Besides that, the rising incidences of obesity along increasing geriatric population will propel the growth of catheter-directed thrombolysis market. Moreover, the availability of emergency medical services and favourable health insurance coverage will also upsurge the growth of catheter-directed thrombolysis market. The scarcity of high health infrastructure in low economic countries will restrain the growth of catheter-directed thrombolysis market over the forecast period. Furthermore, a minor risk associated with the catheter-directed thrombolysis procedure will also restrain the growth of this market to some extent.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5143

Thrombolysis is the therapeutic therapy to treat the clots in blot vessel and improve the blood flow to prevent the damage of tissue and organs. Thrombolysis can be done by injection of clot-busting drugs through an intravenous (IV) line or through a catheter which delivers the drugs directly to the blocking sites. Catheter-directed thrombolysis is a minimal invasive treatment which resolves the issue of clotted blood in the blood vessel. When the blood in the body has improper flow, it gets started to coagulate, which results the formation of semi-solid gel or clouting of blood. The blood clot may continue to grow within the blood vessel and blocks the blood flow within that blood vessel, this may cause the damage of tissue or organ.  The equipment of catheter-directed thrombolysis includes an x-ray camera, catheter, special medications and a medical device is used to dissolve the blood clots.  Along with x-ray camera and catheter, this equipment consists of a radiographic table, one or two x-ray tubes and a monitor to visualize the procedure. The x-ray imaging is used for guiding the medication to the site of the blood clot. X-ray machine produces the video of entire procedure which may visualize on a monitor. A catheter used during the thrombolysis, long, thin and hollow plastic tube. These catheters are designed in such way that medication can be easily delivered to the blood clotted site. Some other devices are also used with equipment during the procedure, such as ultrasound machine and other devices to monitor the heartbeat and blood pressure.

Catheter-directed Thrombolysis Market: Key Players 

Examples of some of the market participants in Catheter-directed Thrombolysis market identified across the value chain include Angio Dynamics, Inc., Boston Scientific Corporation, iVascular SLU, Straub Medical AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5143

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5143

Catheter-directed Thrombolysis Market: Segmentation

The global Catheter-directed Thrombolysis market is classified on the basis of delivery mode, indication, end user and geographic region.

[307 Pages Report] The global hemostasis products market is estimated to garner US$ 2,638 Million while exhibiting a 5.3% CAGR during the forecast period. The growing support from several governments is likely to fuel the market growth in the coming years. The industry is expected to secure US$ 1,580 Million in 2022.

Data points	Key Statistics
Global Hemostasis Products Market CAGR (2022-to 2032)	5.3%
Global Hemostasis Products Market Size (2022)	US$ 1,580 Million
Global Hemostasis Products Market Size (2032)	US$ 2,638 Million

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15386

High-level technological advancements, strong economies, and a swarming pool of patients with a variety of blood disorders are the chief factors that will boost the market for hemostasis products in the near future. The leading causes of surgeries are cardiovascular disease and stroke, cancer, and injury. And any surgical procedure can develop severe complications and result in uncontrollable bleeding thus increasing the demand for hemostasis products.

The rapidly growing medical tourism sector coupled with the high investment made by governments of various countries towards the growth of the healthcare sector will provide lucrative opportunities for the growth of the market. The high expenses related to hemostasis products and stringent regulatory policies and the use of off-label products are projected to restrain the market’s growth over the forecast period.

The topical hemostasis product segment is likely to offer remunerative opportunities for the global hemostasis products market. Several emerging economies are making significant developments in their technological sector, thereby, providing lucrative opportunities to players in the market.

Key Takeaways:

• The global hemostasis products market is estimated at USD 1,501 Million in 2021
• By product, the topical hemostat segment accounts for a market share of 68.5% in 2021
• By application, the myocardial infarction segment accounts for the highest market share of 19.5% during the forecasting period.
• Market in the U.S to procure a market share of 29.5% during the assessment period.

“The increasing number of trauma and surgical cases, technological advancements in the fields of hemostasis products, and an increase in the prevalence of blood disorders are expected to fuel the demand for hemostasis products market over the forecast period”

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15386

Competitive Landscape

Key players in the global hemostasis products market are Medtronic, Johnson & Johnson, Baxter International, Pfizer, Becton, Dickinson, and Company (BD), B. Braun Melsungen AG, Tricol Biomedical, Hemostasis LLC, Teleflex Incorporated, CuraMedical BV, among various others

Recent updates from the industry are:

• In July 2021- Baxter International Inc announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClotPolysaccharide Hemostatic System from CryoLife, Inc. The transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio across the hospital, including in the operating room. PerClot has a global commercial presence with sales in more than 35 countries worldwide.
• Hemostasis is committed to producing high quality medical devices that are safe and effective for their intended use. Hemostasis introduced. BoneSeal bone hemostat is a new generation, absorbable solution providing immediate and long-term hemostasis without immediately dissolving. BoneSeal hemostat works quickly and delivers better results for you and your patients.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15386

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global hemostasis products market presenting a historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Product (Topical hemostasis products, Infusible hemostasis products, Advanced hemostasis products) by Application (Trauma, Surgery, Hemophilia, Myocardial infarction, Others) and Region (North America, Europe, APAC, MEA, and Latin America)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[341 Pages Report] Since the common cold is a viral infection, there is no genuine treatment; nonetheless, there is a well-established market for symptom relief that attracts a lot of interest, demand, and spending.

As per Future Market Insights’ latest industry analysis, the valuation for the global throat sprays market was around US$ 465.7 Mn in 2021 and is projected to exhibit a CAGR growth of close to 2.1% over the forecast period, with an estimated valuation of US$ 586.1 Mn in 2032.

Attributes	Key Insights
Throat Spray Market Base Year Value (2021)	US$ 465.7 Mn
Estimated Market Size (2022)	US$ 473.8 Mn
Projected Market Valuation (2032)	US$ 586.1 Mn
Value-based CAGR (2022-2032)	2.1%
Market Share of Top 5 Countries	62.0%

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15391

The widespread proliferation of viral infections in recent years has increased the demand for products that boost immunity. Infections can spread through a variety of channels, even with the strictest precautions. Healthcare industry players are now looking for herbal products that enhance immunity with minimal adverse effects, in order to reduce the associated risks and to cater to the demand for treatments with less detrimental impact.

Herbal infusions, cold beverages, lozenges, and candies containing herbal extracts with calming or numbing elements are frequently the first option of treatment for moderate sore throat symptoms. However, the chemicals in lozenges and sweets are not often directed at the mouth cavity and are delivered relatively slowly. Using a throat spray is a superior and practical treatment option for a sore throat, which is also highly targeted for symptom relief.

“Growing preference for natural-ingredient based throat sprays, along with wide availability of OTC medicines across online sales channels will create opportunities for growth in the market over the forecast period,” says an FMI analyst.

Key Takeaways:

• Based on product type, sales of anesthetic throat sprays will gain traction through 2032.
• In terms of spray type, the pump and dispensers segment will hold around 2% of the total market share by 2032.
• By capacity, demand for 20-30 ml throat sprays will gain traction at a 4% CAGR during the forecasted years.
• Hospital pharmacies will dominate the market by 2032. The segment held around 4% of the total market share in 2021.
• The U.S. will lead the North America throat sprays market through 2032.
• Demand for throat sprays in Germany will grow at a 2.9% CAGR over the forecast period.
• Sales in the China throat sprays market will increase at a 1.9% CAGR over the assessment period.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15391

Competition Landscape

Research, investment in R&D, strategic collaborations, and technology play a vital role in the throat sprays market growth. Manufacturers and integrators commonly use acquisitions, collaborations, promotions, expansions, and product launches to transfer technology and broaden their customer base internationally. For instance:

• In June 2021, URSATEC developed a melatonin spray – 100% free from preservatives. It is an effective sleep spray, which is void of any kind of preservatives, for better tolerability and safe use.
• In March 2022, Procter & Gamble announced that it would expand its manufacturing facility located at 100 Swing Road in Greensboro by 80,000 square feet and create an additional 46 jobs. The company plans to invest $110 million in the expansion.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the throat sprays market in its latest study, presenting a historical demand assessment of 2015 – 2021 and projections for 2022 – 2032.

The research study is based on the spray type – (anaesthetics throat sprays, anti-inflammatory throat sprays, pain relief throat sprays, anti-bacterial throat sprays, and natural extract throat sprays), by closures (aerosol sprays, and pump & dispensers), by capacity (5 ml, 10-15 ml, 20-30 ml, and >30 ml), by distribution channel (retail store chains, drug stores, hospital pharmacies, and online pharmacies), across seven key regions of the world.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15391

Key Market Segments Covered in Throat Sprays Industry Research

Spray Type:

• Anaesthetics Throat Sprays
• Anti-inflammatory Throat Sprays
• Pain Relief Throat Sprays
• Anti-bacterial Throat Sprays
• Natural Extract Throat Sprays

Closures:

• Aerosol Sprays
• Pump and Dispensers

Capacity:

• 5 ml
• 10-15 ml
• 20-30 ml
• >30 ml

Distribution Channel:

• Retail Store Chains
• Drug Stores
• Hospital Pharmacies
• Online Pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs